Finance

Analyzing the Insider Data for Catalyst Biosciences, Inc. (CBIO)

Recent insider trends for Catalyst Biosciences, Inc. (NASDAQ:CBIO) have caught the attention of investors. Analysts monitor insider data to understand the sentiment of a company’s largest and most important shareholders. CBIO’s insider trading patterns have some implications for where the stock might be headed.

Institutions own 22.19% of Catalyst Biosciences, Inc. (CBIO)’s shares. The total value of these holdings, in millions, is $41. Among active positions in the latest quarter, 7 holders increased their positions by a total of 179689 shares, 12 holders decreased the positions by a total of 128986 shares, and 7 holders held their positions. This works out to a net increase in ownership of 50703 shares, and suggests that institutions are feeling bullish about the stock.

Among new and sold out positions, 4 holders initiated new positions by a total of 3981 shares and 6 holders exited their positions by a total of 114272 shares. This nets out to a decrease of 110291 shares and is another bearish sign for CBIO.

Insider ownership increased by a total of 0 shares, which suggests that CBIO’s key executives are feeling more optimistic about the outlook for the stock. The data from the past twelve months tells a similar story: ownership increased by a net of 0 shares.



Comparing the number of shares sold short over time is a method analysts often use to get a reading on investor sentiment. Catalyst Biosciences, Inc. (NASDAQ:CBIO)’s short interest is 355900 shares, or 9.73% of the float. This represents a decrease of -30% in the number of shares being shorted compared to the previous reading, and implies that investors felt less pessimistic about the stock during the past two weeks.

Supplementing insider data with technical indicators can help an investor form a more complete view on the outlook for a stock. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that CBIO is a Strong buy, which implies that CBIO is expected to outperform the market based on prior trading patterns.

Conclusion




Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bullish. Technical indicators (also) suggest that Catalyst Biosciences, Inc. (NASDAQ:CBIO) is undervalued.

Previous ArticleNext Article

Related Post

Dissecting the Insider Trading Patterns of Symante... Recent insider trends for Symantec Corporation (NASDAQ:SYMC) have caught the attention of investors. Insider data is useful because it can reveal what...
Does The Kroger Co. (KR) Present Much Upside ? The Kroger Co. (NYSE:KR) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision. Now trading...
Are Investors Buying or Selling Vale S.A. (VALE), ... Recent insider trends for Vale S.A. (NYSE:VALE) have caught the attention of investors. Patters in insider activity can help analysts formulate an out...
Banco Bradesco S.A. (BBD) vs. Acxiom Corporation (... Banco Bradesco S.A. (NYSE:BBD) shares are up more than 12.70% this year and recently decreased -1.64% or -$0.17 to settle at $10.47. Acxiom Corporatio...
CarMax Inc. (KMX) vs. Carvana Co. (CVNA): Breaking... CarMax Inc. (NYSE:KMX) and Carvana Co. (NYSE:CVNA) are the two most active stocks in the Auto Dealerships industry based on today’s trading volumes. I...